Anticoagulants
"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent clotting.
Descriptor ID |
D000925
|
MeSH Number(s) |
D27.505.954.502.119
|
Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 | 2001 | 1 | 0 | 1 | 2002 | 1 | 0 | 1 | 2004 | 1 | 0 | 1 | 2007 | 1 | 0 | 1 | 2013 | 0 | 2 | 2 | 2014 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2018 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2022 | 0 | 1 | 1 | 2023 | 0 | 1 | 1 | 2024 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
McElroy S, Cramer E, Amos L. COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics. Thromb Res. 2024 Nov; 243:109169.
-
Kelley-Quon LI, Acker SN, St Peter S, Goldin A, Yousef Y, Ricca RL, Mansfield SA, Sulkowski JP, Huerta CT, Lucas DJ, Rialon KL, Christison-Lagay E, Ham PB, Rentea RM, Beres AL, Kulaylat AN, Chang HL, Polites SF, Diesen DL, Gonzalez KW, Wakeman D, Baird R. Screening and Prophylaxis for Venous Thromboembolism in Pediatric Surgery: A Systematic Review. J Pediatr Surg. 2024 Oct; 59(10):161585.
-
Feldman K, Heble DE, Hendrickson RJ, Fischer RT. Hepatic artery thrombosis and use of anticoagulants and antiplatelet agents in pediatric liver transplantation. Pediatr Transplant. 2024 02; 28(1):e14516.
-
Feldman K, Duncan RG, Nguyen A, Cook-Wiens G, Elad Y, Nuckols T, Pevnick JM. Will Apple devices' passive atrial fibrillation detection prevent strokes? Estimating the proportion of high-risk actionable patients with real-world user data. J Am Med Inform Assoc. 2022 05 11; 29(6):1040-1049.
-
Sun LR, Linds A, Sharma M, Rafay M, Vadivelu S, Lee S, Brand?o LR, Appavu B, Estepp JH, Hukin J, Hassanein SMA, Chan A, Beslow LA. Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study. Pediatr Neurol. 2020 10; 111:59-65.
-
Amos LE, Silvey M, Hall M, Witmer CM, Carpenter SL. Primary thromboprophylaxis in hospitalized children: A multi-center retrospective analysis. Thromb Res. 2019 Apr; 176:1-7.
-
Claudio-Campos KI, Gonz?lez-Santiago P, Renta JY, Rodr?guez J, Carrasquillo K, Gaedigk A, Roche A, Ducong? J. CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements. Pharmacogenomics. 2019 01; 20(1):3-8.
-
DeSimone RA, Myers GD, Guest EM, Shi PA. Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis. J Clin Apher. 2019 Aug; 34(4):487-489.
-
Wagner J, Abdel-Rahman SM. Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review. Pediatrics. 2015 May; 135(5):e1333-6.
-
Shaw K, Amstutz U, Hildebrand C, Rassekh SR, Hosking M, Neville K, Leeder JS, Hayden MR, Ross CJ, Carleton BC. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children. Pediatr Blood Cancer. 2014 Jun; 61(6):1055-62.
|
People ![Expand Description](https://researchers.childrensmercy.org/Framework/Images/info.png) People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|